First Time Loading...

IRadimed Corp
NASDAQ:IRMD

Watchlist Manager
IRadimed Corp Logo
IRadimed Corp
NASDAQ:IRMD
Watchlist
Price: 42 USD 3.42% Market Closed
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one IRMD stock under the Base Case scenario is 30.94 USD. Compared to the current market price of 42 USD, IRadimed Corp is Overvalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IRMD Relative Value
Base Case
30.94 USD
Overvaluation 26%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.1
P/S
P/S
Price to Sales
8.1
vs History
60
vs Industry
17
Median 3Y
9.2
Median 5Y
8.5
Industry
2.4
Forward
7.2
More Details
30.9
P/E
P/E
Price to Earnings
30.9
vs History
71
vs Industry
19
Median 3Y
38.4
Median 5Y
38.1
Industry
23.2
Forward
26.9
More Details
39.5
P/OCF
P/OCF
Price to OCF
39.5
vs History
50
vs Industry
9
Median 3Y
41.8
Median 5Y
39.7
Industry
15.5
More Details
97.4
P/FCFE
P/FCFE
Price to FCFE
97.4
vs History
14
vs Industry
6
Median 3Y
56.1
Median 5Y
47.6
Industry
23.5
More Details
7.4
P/B
P/B
Price to Book Value
7.4
vs History
23
vs Industry
10
Median 3Y
6.8
Median 5Y
5.6
Industry
2.2
More Details
7.4
EV/S
EV/S
Enterprise Value to Sales
7.4
vs History
53
vs Industry
18
Median 3Y
8.2
Median 5Y
7.5
Industry
2.5
Forward
6.5
More Details
9.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.6
vs History
53
vs Industry
25
Median 3Y
10.8
Median 5Y
9.7
Industry
5.2
More Details
23.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
23.2
vs History
76
vs Industry
15
Median 3Y
27.9
Median 5Y
27.6
Industry
12.5
Forward
21.3
More Details
24.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
24.1
vs History
77
vs Industry
21
Median 3Y
30.6
Median 5Y
28.3
Industry
17.2
Forward
22.9
More Details
35.8
EV/OCF
EV/OCF
Enterprise Value to OCF
35.8
vs History
49
vs Industry
11
Median 3Y
36.9
Median 5Y
35.6
Industry
15.1
More Details
88.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
88.3
vs History
14
vs Industry
5
Median 3Y
49.2
Median 5Y
41.5
Industry
19.7
More Details
11.9
EV/IC
EV/IC
Enterprise Value to IC
11.9
vs History
63
vs Industry
7
Median 3Y
15.7
Median 5Y
12.8
Industry
2
More Details

Multiples Across Competitors

IRMD Competitors Multiples
IRadimed Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
IRadimed Corp
NASDAQ:IRMD
531.7m USD 8.1 30.9 23.2 24.1
US
Abbott Laboratories
NYSE:ABT
184.3B USD 4.6 32.7 19.3 28.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
131.8B USD 18 66.3 54.4 68.2
US
Stryker Corp
NYSE:SYK
124.8B USD 6 37.1 24.1 29.7
IE
Medtronic PLC
NYSE:MDT
107.6B USD 3.3 25.6 13.6 19.3
US
Boston Scientific Corp
NYSE:BSX
105.8B USD 7.2 59.9 30.6 45.1
US
Becton Dickinson and Co
NYSE:BDX
67.5B USD 3.5 55.4 18.6 39.2
DE
Siemens Healthineers AG
XETRA:SHL
58.1B EUR 2.7 38.3 18.4 31
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
368.4B CNY 10.7 32.5 28.3 28.3
US
Edwards Lifesciences Corp
NYSE:EW
50.7B USD 8.3 35.9 26.1 28.2
US
Dexcom Inc
NASDAQ:DXCM
49.9B USD 13.1 78 58.3 75.9

See Also

Summary
IRMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
IRMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IRMD stock valuation using valuation multiples.
Wall Street Estimates
IRMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IRMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.